A secretory system for bacterial production of high-profile protein targets

Protein Science

Volumn 20, Issue 3, 2011, Pages 597-609

  Kotzsch, Alexander ^a   Vernet, Erik ^a   Hammarström, Martin ^b   Berthelsen, Jens ^a   Weigelt, Johan ^b   Gräslund, Susanne ^b   Sundström, Michael ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Escherichia coli; Extracellular protein expression; High throughput protein expression; OmpA; OmpF; OsmY

Indexed keywords

MEMBRANE PROTEIN; OSMOTICALLY INDUCIBLE PROTEIN Y; OUTER MEMBRANE PROTEIN A; OUTER MEMBRANE PROTEIN F; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CULTURE MEDIUM; CYTOPLASM; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION;

BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL SECRETION SYSTEMS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; MASS SPECTROMETRY; PERIPLASMIC BINDING PROTEINS; PORINS; PROMOTER REGIONS, GENETIC; RECOMBINANT FUSION PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 79952174790     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1002/pro.593     Document Type: Article

References (60)

1. Berndt C, Lillig CH, Holmgren A (2008) Thioredoxins and glutaredoxins as facilitators of protein folding. Biochim Biophys Acta 1783:641-650.
2. Baneyx F, Mujacic M (2004) Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 22:1399-1408.
3. Lazdunski CJ (1988) Pore-forming colicins: synthesis, extracellular release, mode of action, immunity. Biochimie 70:1291-1296.
4. Filloux A, Voulhoux R, Ize B, Gerard F, Ball G, Wu LF (2002) Use of colicin-based genetic tools for studying bacterial protein transport. Biochimie 84:489-497. (Pubitemid 35350880)
5. Hughes C, Stanley P, Koronakis V (1992) E. coli hemolysin interactions with prokaryotic and eukaryotic cell membranes. Bioessays 14:519-525.
6. Qian ZG, Xia XX, Choi JH, Lee SY (2008) Proteome-based identification of fusion partner for high-level extracellular production of recombinant proteins in Escherichia coli. Biotechnol Bioeng 101:587-601.
7. Xia XX, Han MJ, Lee SY, Yoo JS (2008) Comparison of the extracellular proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. Proteomics 8:2089-2103.
8. Nandakumar MP, Cheung A, Marten MR (2006) Proteomic analysis of extracellular proteins from Escherichia coli W3110. J Proteome Res 5:1155-1161. (Pubitemid 43727793)
9. Choi JH, Lee SY (2004) Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl Microbiol Biotechnol 64:625-635. (Pubitemid 38822625)
10. Sivakesava S, Xu ZN, Chen YH, Hackett J, Huang RC, Lam E, Lam TL, Siu KL, Wong RSC, Wong WKR (1999) Production of excreted human epidermal growth factor (hEGF) by an efficient recombinant Escherichia coli system. Process Biochem 34:893-900. (Pubitemid 29513361)
11. Hsiung HM, Cantrell A, Luirink J, Oudega B, Veros AJ, Becker GW (1989) Use of Bacteriocin Release Protein in E. Coli for Excretion of Human Growth-Hormone into the Culture-Medium. Biotechnol 7:267-271.
12. Kato C, Kobayashi T, Kudo T, Furusato T, Murakami Y, Tanaka T, Baba H, Oishi T, Ohtsuka E, Ikehara M, Yanagida T, Kato H, Moriyama S, Horikoshi K (1987) Construction of an excretion vector and extracellular production of human growth hormone from Escherichia coli. Gene 54:197-202. (Pubitemid 17100371)
13. Zhang G, Brokx S, Weiner JH (2006) Extracellular accumulation of recombinant proteins fused to the carrier protein YebF in Escherichia coli. Nat Biotechnol 24:100-104. (Pubitemid 43083173)
14. Jeong KJ, Lee SY (2002) Excretion of human beta-endorphin into culture medium by using outer membrane protein F as a fusion partner in recombinant Escherichia coli. Appl Environ Microbiol 68:4979-4985. (Pubitemid 35154808)
15. Yang J, Moyana T, MacKenzie S, Xia Q, Xiang J (1998) One hundred seventy-fold increase in excretion of an FV fragment-tumor necrosis factor alpha fusion protein (sFV/TNF-alpha) from Escherichia coli caused by the synergistic effects of glycine and triton X-100. Appl Environ Microbiol 64:2869-2874. (Pubitemid 28363154)
16. Sommer B, Friehs K, Flaschel E (2010) Efficient production of extracellular proteins with Escherichia coli by means of optimized coexpression of bacteriocin release proteins. J Biotechnol 145:350-358.
17. Thie H, Schirrmann T, Paschke M, Dubel S, Hust M (2008) SRP and Sec pathway leader peptides for antibody phage display and antibody fragment production in E. coli. Nat Biotechnol 25:49-54. (Pubitemid 351713600)
18. Shokri A, Sanden AM, Larsson G (2003) Cell and process design for targeting of recombinant protein into the culture medium of Escherichia coli. Appl Microbiol Biotechnol 60:654-664. (Pubitemid 36286671)
19. Griep RA, van Twisk C, Kerschbaumer RJ, Harper K, Torrance L, Himmler G, van der Wolf JM, Schots A (1999) pSKAP/S: An expression vector for the production of single-chain Fv alkaline phosphatase fusion proteins. Protein Expr Purif 16:63-69. (Pubitemid 29321725)
20. King DJ, Byron OD, Mountain A, Weir N, Harvey A, Lawson AD, Proudfoot KA, Baldock D, Harding SE, Yarranton GT, Owens RJ (1993) Expression, purification and characterization of B72.3 Fv fragments. Biochem J 290(Pt 3):723-729. (Pubitemid 23100430)
21. Fernandez LA, de Lorenzo V (2001) Formation of disulphide bonds during secretion of proteins through the periplasmic-independent type I pathway. Mol Microbiol 40:332-346. (Pubitemid 32391629)
22. Fernandez LA, Sola I, Enjuanes L, de Lorenzo V (2000) Specific secretion of active single-chain Fv antibodies into the supernatants of Escherichia coli cultures by use of the hemolysin system. Appl Environ Microbiol 66:5024-5029.
23. Cowan SW, Schirmer T, Rummel G, Steiert M, Ghosh R, Pauptit RA, Jansonius JN, Rosenbusch JP (1992) Crystal-Structures Explain Functional-Properties of 2 Escherichia-Coli Porins. Nature 358:727-733.
24. Graslund S, Sagemark J, Berglund H, Dahlgren LG, Flores A, Hammarstrom M, Johansson I, Kotenyova T, Nilsson M, Nordlund P, Weigelt J (2008) The use of systematic N- and C-terminal deletions to promote production and structural studies of recombinant proteins. Protein Expr Purif 58:210-221.
25. Tobias JW, Shrader TE, Rocap G, Varshavsky A (1991) The N-end rule in bacteria. Science 254:1374-1377. (Pubitemid 21917472)
26. Missiakas D, Raina S (1997) Protein folding in the bacterial periplasm. J Bacteriol 179:2465-2471. (Pubitemid 27164541)
27. Huang RC, Lam E, Chen YH, Hackett J, Lam TL, Liu D, Ma MC, Siu KL, Sivakesava S, Xu ZN, Wong RSC, Wong WKR (1999) Human epidermal growth factor excreted by recombinant Escherichia coli K-12 has the correct N-terminus and is fully bioactive. Process Biochem 35:1-5. (Pubitemid 29513182)
28. Li Y, Chen CX, von Specht BU, Hahn HP (2002) Cloning and hemolysin-mediated secretory expression of a codon-optimized synthetic human interleukin-6 gene in Escherichia coli. Protein Expr Purif 25:437-447. (Pubitemid 35293972)
29. Miksch G, Ryu S, Risse JM, Flaschel E (2008) Factors that influence the extracellular expression of streptavidin in Escherichia coli using a bacteriocin release protein. Appl Microbiol Biotechnol 81:319-326.
30. Henderson IR, Navarro-Garcia F, Desvaux M, Fernandez RC, Ala'Aldeen D (2004) Type V protein secretion pathway: the autotransporter story. Microbiol Mol Biol R 68:692-744. (Pubitemid 39628534)
31. Stathopoulos C, Hendrixson DR, Thanassi DG, Hultgren SJ, St Geme JW, Curtiss R (2000) Secretion of virulence determinants by the general secretory pathway in Gram-negative pathogens: an evolving story. Microbes Infect 2:1061-1072. (Pubitemid 30664220)
32. Francetic O, Pugsley AP (1996) The cryptic general secretory pathway (gsp) operon of Escherichia coli K-12 encodes functional proteins. J Bacteriol 178:3544-3549.
33. Pautsch A, Schulz GE (1998) Structure of the outer membrane protein A transmembrane domain. Nat Struct Biol 5:1013-1017. (Pubitemid 28506635)
34. Freudl R, Schwarz H, Stierhof Y, Gamon K, Hindennach I, Henning U (1986) An Outer-Membrane Protein (Ompa) of Escherichia-Coli K-12 Undergoes a Conformational Change during Export. J Biol Chem 261:1355-1361.
35. Sen K, Nikaido H (1991) Trimerization of an Invitro Synthesized Ompf Porin of Escherichia-Coli Outer-Membrane. J Biol Chem 266:11295-11300. (Pubitemid 21906946)
36. Kleinschmidt JH (2003) Membrane protein folding on the example of outer membrane protein A of Escherichia coli. Cell Mol Life Sci 60:1547-1558.
37. Vertommen D, Depuydt M, Pan J, Leverrier P, Knoops L, Szikora JP, Messens J, Bardwell JCA, Collet JF (2008) The disulphide isomerase DsbC cooperates with the oxidase DsbA in a DsbD-independent manner. Mol Microbiol 67:336-349. (Pubitemid 350295830)
38. Sen K, Nikaido H (1991) Lipopolysaccharide Structure Required for Invitro Trimerization of Escherichia-Coli Ompf Porin. J Bacteriol 173:926-928.
39. Chen R, Henning U (1996) A periplasmic protein (Skp) of Escherichia coli selectively binds a class of outer membrane proteins. Mol Microbiol 19:1287-1294. (Pubitemid 26112812)
40. Thome BM, Hoffschulte HK, Schiltz E, Muller M (1990) A protein with sequence identity to Skp (FirA) supports protein translocation into plasma membrane vesicles of Escherichia coli. FEBS Lett 269:113-116. (Pubitemid 20245330)
41. Kesty NC, Kuehn MJ (2004) Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles. J Biol Chem 279:2069-2076. (Pubitemid 38084479)
42. Yeats C, Bateman A (2003) The BON domain: a putative membrane-binding domain. Trends Biochem Sci 28:352-355. (Pubitemid 36851614)
43. Oh JT, Cajal Y, Skowronska EM, Belkin S, Chen JH, Van Dyk TK, Sasser M, Jain MK (2000) Cationic peptide antimicrobials induce selective transcription ofmicF and osmY in Escherichia coli. BiochimBiophys Acta 1463:43-54. (Pubitemid 30019234)
44. Teriete P, Yao Y, Kolodzik A, Yu J, Song H, Niederweis M, Marassi FM (2010) Mycobacterium tuberculosis Rv0899 adopts a mixed alpha/beta-structure and does not form a transmembrane beta-barrel. Biochemistry 49:2768-2777.
45. Gerard F, Brooks MA, Barreteau H, Touze T, Graille M, Bouhss A, Blanot D, van Tilbeurgh H, Mengin-Lecreulx D (2010) X-ray structure and site-directed mutagenesis analysis of the Escherichia coli colicin M immunity protein. J Bacteriol 193:205-214.
46. Lu H, Yu M, Sun Y, Mao W, Wang Q, Wu M, Han W (2007) Expression and purification of bioactive high-purity mouse monokine induced by IFN-gamma in Escherichia coli. Protein Expr Purif 55:132-138. (Pubitemid 47259687)
47. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM(1995)HumanMig chemokine: biochemical and functional characterization. J ExpMed 182:1301-1314.
48. Egesten A, Eliasson M, Johansson HM, Olin AI, Morgelin M, Mueller A, Pease JE, Frick IM, Bjorck L (2007) The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195:684-693.
49. Putz U, Harwell C, Nedivi E (2005) Soluble CPG15 expressed during early development rescues cortical progenitors from apoptosis. Nat Neurosci 8:322-331. (Pubitemid 40300189)
50. Saremba S, Nickel J, Seher A, Kotzsch A, Sebald W, Mueller TD (2008) Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand. FEBS J 275:172-183. (Pubitemid 350294073)
51. Daly R, Hearn MT (2006) Expression of the human activin type I and II receptor extracellular domains in Pichia pastoris. Protein Expr Purif 46:456-467.
52. Clegg RA, Holt C (2009) An E. coli over-expression system for multiply-phosphorylated proteins and its use in a study of calcium phosphate sequestration by novel recombinant phosphopeptides. Protein Expr Purif 67:23-34.
53. Saad FA, Salih E, Glimcher MJ (2008) Identification of osteopontin phosphorylation sites involved in bone remodeling and inhibition of pathological calcification. J Cell Biochem 103:852-856. (Pubitemid 351240620)
54. Stubbs JT, III (1996) Generation and use of recombinant human bone sialoprotein and osteopontin for hydroxyapatite studies. Connect Tissue Res 35:393-399.
55. Gileadi O, Burgess-Brown NA, Colebrook SM, Berridge G, Savitsky P, Smee CE, Loppnau P, Johansson C, Salah E, Pantic NH (2008) High throughput production of recombinant human proteins for crystallography. Methods Mol Biol 426:221-246.
56. Marley J, Lu M, Bracken C (2001) A method for efficient isotopic labeling of recombinant proteins. J Biomol NMR 20:71-75. (Pubitemid 32519656)
57. Mooij WT, Mitsiki E, Perrakis A (2009) ProteinCCD: enabling the design of protein truncation constructs for expression and crystallization experiments. Nucleic Acids Res 37:W402-405.
58. Sagemark J, Kraulis P, Weigelt J (2010) A software tool to accelerate design of protein constructs for recombinant expression. Protein Expr Purif 72:175-178.
59. Page R, Moy K, Sims EC, Velasquez J, McManus B, Grittini C, Clayton TL, Stevens RC (2004) Scalable high-throughput micro-expression device for recombinant proteins. Biotechniques 37:364,366,368 passim.
60. van den Berg S, Lofdahl PA, Hard T, Berglund H (2006) Improved solubility of TEV protease by directed evolution. J Biotechnol 121:291-298.